UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis

Arthritis care & research (2010), 2015-11, Vol.67 (11), p.1503-1512

2015

Volltextzugriff (PDF)

Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis

Arthritis care & research (2010), 2018-11, Vol.70 (11), p.1598-1606

2018

Volltextzugriff (PDF)

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

Annals of the rheumatic diseases, 2016-11, Vol.75 (11), p.1958-1963

2016

Volltextzugriff (PDF)

Inflammatory Foot Involvement in Spondyloarthritis: From Tarsitis to Ankylosing Tarsitis

Frontiers in medicine, 2021-10, Vol.8, p.730273-730273

2021

Volltextzugriff (PDF)

Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study

Arthritis & rheumatology (Hoboken, N.J.), 2014-02, Vol.66 (2), p.379-389

2014

Volltextzugriff (PDF)

The role of γδ T cells in the immunopathogenesis of inflammatory diseases: from basic biology to therapeutic targeting

Journal of leukocyte biology, 2023-11, Vol.114 (6), p.557-570

2023

Volltextzugriff (PDF)

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative

Annals of the rheumatic diseases, 2014-02, Vol.73 (2), p.328-335

2014

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis

Arthritis research & therapy, 2022-08, Vol.24 (1), p.1-187, Article 187

2022

Volltextzugriff (PDF)

Treatment Algorithms in Systemic Lupus Erythematosus

Arthritis care & research (2010), 2015-09, Vol.67 (9), p.1237-1245

2015

Volltextzugriff (PDF)

Inflammatory Back Pain

Rheumatic diseases clinics of North America, 2012-08, Vol.38 (3), p.487-499

2012

Volltextzugriff (PDF)

From undifferentiated SpA to ankylosing spondylitis

Nature reviews. Rheumatology, 2013-11, Vol.9 (11), p.639-641

Burgos-Vargas, Rubén

2013

Volltextzugriff (PDF)

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

Arthritis & rheumatology (Hoboken, N.J.), 2021-03, Vol.73 (3), p.530-541

2021

Volltextzugriff (PDF)

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Scientific reports, 2024-05, Vol.14 (1), p.10342-10342, Article 10342

2024

Volltextzugriff (PDF)

Epidemiology of Spondyloarthritis in México

The American journal of the medical sciences, 2011-04, Vol.341 (4), p.298-300

2011

Volltextzugriff (PDF)

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

Arthritis & rheumatology (Hoboken, N.J.), 2012-05, Vol.64 (5), p.1487-1487

2012

Volltextzugriff (PDF)

Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study

Arthritis care & research (2010), 2023-08, Vol.75 (8), p.1804-1814

2023

Volltextzugriff (PDF)

The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist

Pediatric rheumatology online journal, 2012-05, Vol.10 (1), p.14-14, Article 14

Burgos-Vargas, Ruben

2012

Volltextzugriff (PDF)

Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement

Clinical rheumatology, 2022-03, Vol.41 (3), p.811-818

2022

Volltextzugriff (PDF)

The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and Concerns

Arthritis & rheumatology (Hoboken, N.J.), 2014-10, Vol.66 (10), p.2649-2656

2014

Volltextzugriff (PDF)

Determinants of Discordance Between Criteria for Inactive Disease and Low Disease Activity in Juvenile Idiopathic Arthritis

Arthritis care & research (2010), 2021-12, Vol.73 (12), p.1722-1729

2021

Volltextzugriff (PDF)

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

Arthritis care & research (2010), 2016-05, Vol.68 (5), p.667-672

2016

Volltextzugriff (PDF)

Epidemiology of rheumatic diseases in indigenous populations in Latin-Americans

Clinical rheumatology, 2016-07, Vol.35 (Suppl 1), p.1-3

2016

Volltextzugriff (PDF)

Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial

Journal of rheumatology, 2012-09, Vol.39 (9), p.1859-1866

2012

Volltextzugriff (PDF)

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

Journal of rheumatology, 2019-02, Vol.46 (2), p.190-197

2019

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(267)
Mit Volltextzugriff
(230)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(227)
Life Sciences & Biomedicine
(222)
Rheumatology
(205)
Humans
(176)
Male
(117)
Female
(111)
Adult
(67)
Middle Aged
(59)
Biological And Medical Sciences
(58)
Medical Sciences
(58)
Adolescent
(53)
Child
(53)
Diseases Of The Osteoarticular System
(49)
Ankylosing Spondylitis
(44)
Arthritis
(42)
Treatment Outcome
(42)
Antirheumatic Agents - Therapeutic Use
(39)
Inflammatory Joint Diseases
(39)
Patients
(32)
Severity Of Illness Index
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis

Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group

Inflammatory Foot Involvement in Spondyloarthritis: From Tarsitis to Ankylosing Tarsitis

Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study

The role of γδ T cells in the immunopathogenesis of inflammatory diseases: from basic biology to therapeutic targeting

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative

A randomized, double-blind, placebo-controlled 12-week trial of infliximab in patients with juvenile-onset spondyloarthritis

Treatment Algorithms in Systemic Lupus Erythematosus

Inflammatory Back Pain

From undifferentiated SpA to ankylosing spondylitis

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial

Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Epidemiology of Spondyloarthritis in México

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo

Patient‐Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular‐Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two‐Year Results From an International Phase III Study

The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist

Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients

Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement

The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and Concerns

Determinants of Discordance Between Criteria for Inactive Disease and Low Disease Activity in Juvenile Idiopathic Arthritis

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

Epidemiology of rheumatic diseases in indigenous populations in Latin-Americans

Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

Suchergebnisse filtern